FC
Finepoint Capital’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-309,948
| Closed | -$12.5M | – | 11 |
|
|
2025
Q1 | $12.5M | Sell |
309,948
-8,500
| -3% | -$342K | 0.95% | 9 |
|
|
2024
Q4 | $15M | Buy |
318,448
+61,999
| +24% | +$2.92M | 0.91% | 12 |
|
|
2024
Q3 | $13.5M | Hold |
256,449
| – | – | 0.98% | 13 |
|
|
2024
Q2 | $13.9M | Buy |
256,449
+18,403
| +8% | +$997K | 3.94% | 11 |
|
|
2024
Q1 | $16.7M | Sell |
238,046
-193,647
| -45% | -$13.6M | 4.28% | 9 |
|
|
2023
Q4 | $36M | Hold |
431,693
| – | – | 11.37% | 1 |
|
|
2023
Q3 | $12.7M | Buy |
431,693
+62,600
| +17% | +$1.84M | 6.33% | 8 |
|
|
2023
Q2 | $12M | Sell |
369,093
-44,700
| -11% | -$1.46M | 4.17% | 14 |
|
|
2023
Q1 | $14.6M | Buy |
413,793
+11,000
| +3% | +$387K | 5.56% | 12 |
|
|
2022
Q4 | $18.5M | Buy |
402,793
+22,000
| +6% | +$1.01M | 5.97% | 5 |
|
|
2022
Q3 | $18.4M | Sell |
380,793
-38,640
| -9% | -$1.87M | 6.07% | 4 |
|
|
2022
Q2 | $16.5M | Buy |
+419,433
| New | +$16.5M | 5.7% | 4 |
|